Research & Development

US WorldMeds is committed to the future

In Development

US WorldMeds is committed to improving the lives of our patients, both in the products that we market and in the therapies that are currently under development. This commitment can be seen in our pipeline, where we are diligently working to bring new therapies and new indications to patients across multiple therapeutic areas.

Phases 1 2 3 R 4
Apomorphine Infusion
Idiopathic Parkinson's disease
Lofexidine
Opioid withdrawal symptoms
Melphalan
Multiple myeloma
RimabotulinumtoxinB
Sialorrhea
R = Registration

Ongoing Clinical Trials

Clinical trials are the cornerstone of furthering our mission to improving the lives of patients. US WorldMeds is committed to sponsoring safe and effective trials that help to better the lives of patients.

Drug
Apomorphine Infusion
Condition
Idiopathic Parkinson’s Disease
Phase
3
Study Title
Infusion of Apomorphine: Long-term Safety Study (INFUS-ON)
Link